Andrew Davis

Corporate Officer/Principal at DYNAVAX TECHNOLOGIES CORPORATION

40 year

Health Technology

Consumer Services

Profile

Andrew Davis is currently Director at UTILITY therapeutics Ltd. since 2019 and Chief Business Officer at Dynavax Technologies Corp.
starting in 2024.
Formerly, Mr. Davis was Chairman at VectivBio Holding AG; Director at BioMarck Pharmaceuticals Ltd. from 2020 to 2022; Senior Vice President-Business Development at Ironwood Pharmaceuticals, Inc. in 2021; Senior Vice President-Business Development at Bausch Health US LLC from 2014 to 2016; Vice President-Corporate Development at Bausch Health Cos., Inc.; Chief Business Development Officer at iNova Pharmaceuticals (Pty) Ltd. (South Africa) from 2017 to 2021; and Head-Oncology Business Development at Merck & Co., Inc. from 2016 to 2017.
Education includes undergraduate studies at Boston University.

Andrew Davis active positions

Companies	Position	Start
DYNAVAX TECHNOLOGIES CORPORATION	Corporate Officer/Principal	31/10/2024
UTILITY therapeutics Ltd. UTILITY therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical products for the treatment of urinary tract infections	Director/Board Member	31/07/2019

All active positions of Andrew Davis

Former positions of Andrew Davis

Companies	Position	End
IRONWOOD PHARMACEUTICALS, INC.	Corporate Officer/Principal	21/11/2024
BioMarck Pharmaceuticals Ltd. BioMarck Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops new drugs for the treatment of pulmonary diseases and disorders	Director/Board Member	30/09/2022
iNova Pharmaceuticals (Pty) Ltd. (South Africa) iNova Pharmaceuticals (Pty) Ltd. (South Africa) Pharmaceuticals: MajorHealth Technology Develops and markets healthcare products	Corporate Officer/Principal	30/04/2021
MERCK & CO., INC.	Corporate Officer/Principal	31/08/2017
Bausch Health US LLC Bausch Health US LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures, and markets pharmaceutical products	Corporate Officer/Principal	31/12/2015

See the detail of Andrew Davis's experience

Training of Andrew Davis

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Andrew Davis's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
Merck & Co., Inc. Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines	Health Technology
Dynavax Technologies Corp. Dynavax Technologies Corp. BiotechnologyHealth Technology Develops and commercializes novel products to prevent and treat infectious diseases	Health Technology
Ironwood Pharmaceuticals, Inc. Ironwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets gastrointestinal products	Health Technology
BioMarck Pharmaceuticals Ltd. BioMarck Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops new drugs for the treatment of pulmonary diseases and disorders	Health Technology
Boston University Boston University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Bausch Health US LLC Bausch Health US LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures, and markets pharmaceutical products	Health Technology
Bausch Health Cos., Inc. Bausch Health Cos., Inc. Pharmaceuticals: OtherHealth Technology Manufactures and markets pharmaceutical products	Health Technology
iNova Pharmaceuticals (Pty) Ltd. (South Africa) iNova Pharmaceuticals (Pty) Ltd. (South Africa) Pharmaceuticals: MajorHealth Technology Develops and markets healthcare products	Health Technology
UTILITY therapeutics Ltd. UTILITY therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical products for the treatment of urinary tract infections	Health Technology
VectivBio Holding AG VectivBio Holding AG Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for rare diseases	Health Technology